Bio-Rad Laboratories Inc (BIO)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,569,300 | 8,741,130 | 9,615,250 | 13,667,100 | 9,879,940 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $6,569,300K)
= 0.00
The debt-to-capital ratio of Bio-Rad Laboratories Inc has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt to finance its operations or growth, as its total debt is negligible in comparison to its total capital (which includes debt and equity). This suggests that the company may have a strong financial position with lower financial risk, as it is not heavily leveraged. However, it is important to note that a very low debt-to-capital ratio may also imply missed opportunities for leveraging debt for potential expansion or capital structure optimization.
Peer comparison
Dec 31, 2024